Log In
Print this Print this

Addyi, flibanserin (formerly BIMT-17)

  Manage Alerts
Collapse Summary General Information
Company Sprout Pharmaceuticals Inc.
DescriptionSerotonin (5-HT1A) receptor agonist and 5-HT2A receptor antagonist
Molecular Target Serotonin (5-HT1A) receptor ; Serotonin (5-HT2A) receptor
Mechanism of ActionSerotonin (5-HT1A) receptor agonist; Serotonin (5-HT2A) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationSexual dysfunction
Indication DetailsTreat hypoactive sexual desire disorder (HSDD) in premenopausal women
Regulatory Designation U.S. - Undisclosed Review (Treat hypoactive sexual desire disorder (HSDD) in premenopausal women)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today